Sponsor:
Weill Medical College of Cornell University
Code:
NCT07485738
Conditions
CABG Graft Integrity
CABG
Blood Flow
Transit-time Flow Measurement
Heart Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Transit-Time Flow Measurement (TTFM)
Brief summary:
Conditions
CABG Graft Integrity
CABG
Blood Flow
Transit-time Flow Measurement
Heart Disease
Study ID
NCT07485738
Start date
Mar 30, 2026
Status verified date
Apr, 2026
Completion date
Mar, 2032
Anticipated
Primary completion date
Mar, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
1242 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
active comparator: Transit-Time Flow Measurement (TTFM)
no intervention: No Transit-Time Flow Measurement
Interventions
Transit-Time Flow Measurement (TTFM)
Primary outcome measure
Central contacts
Locations
Weill Cornell Medicine/NewYork Presbyterian Hospital
Recruiting
New York, New York, United States, 10022
Contacts
Principal Investigator:
Mario Gaudino, MD, PhD, MSCE, FEBCTS, FACC, F
Sponsor
Weill Medical College of Cornell University
Last update posted
Apr 22, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-04-22.